EVALUATION OF 5-CARBAMOYLMETHYLURIDINE AS AN INDICATOR OF TUMOR BURDEN IN LUNG-CANCER PATIENTS

被引：1

作者：

CHHEDA, GB

ANTKOWIAK, JG

TAKITA, H

BHARGAVA, AK

TWOREK, HA

机构：

[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THORAC SURG,BUFFALO,NY 14263

[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT LAB MED,BUFFALO,NY 14263

来源：

NUCLEOSIDES & NUCLEOTIDES | 1990年 / 9卷 / 03期

关键词：

D O I：

10.1080/07328319008045165

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Elevation of 5-carbamoylmethyluridine in the urines of non-small lung carcinoma patients suggests that this nucleoside may be used as an indicator of tumor burden for these patients. © 1990, Taylor & Francis Group, LLC. All rights reserved.

引用

页码：441 / 442

页数：2